Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Myers, Robert W., Guan, Hong-Ping, Ehrhart, Juliann, Petrov, Aleksandr, Prahalada, Srinivasa, Tozzo, Effie, Yang, Xiaodong, Kurtz, Marc M. +41 more·2017·Science

Cited by (352)

Items 201–300 of 352

  1. Fine-tuning AMPK in physiology and disease using point-mutant mouse models
    Naghmana Ashraf, Jeanine L. Van Nostrand · 2024 · Disease Models & Mechanisms
  2. AMPK regulates the maintenance and remodelling of the neuromuscular junction
    Sean Y. Ng, Andrew I. Mikhail, Stephanie R. Mattina, Salah A. Mohammed, Showkhin Khan, Eric M. Desjardins, Changhyun Lim, Stuart M. Phillips, Gregory R. Steinberg, Vladimir Ljubicic · 2024 · Molecular Metabolism
  3. Activation of AMPK for a Break in Hepatic Lipid Accumulation and Circulating Cholesterol
    Marc Foretz, Benoı̂t Viollet · 2018 · EBioMedicine
  4. Hyperlipidemias and Obesity
    Marc Thiriet · 2018 · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems
  5. Mechanism and cellular actions of the potent AMPK inhibitor BAY-3827
    Conchita Fraguas Bringas, Mohd Syed Ahangar, Joyceline Cuenco, Hongling Liu, Alex Bernard Addinsall, Maria Lindahl, Ashley J. Ovens, Mark Anthony Febbraio, Marc Foretz, Olga Göransson et al. · 2025 · Science Advances
  6. Improving Mitochondrial Function in Skeletal Muscle Contributes to the Amelioration of Insulin Resistance by Nicotinamide Riboside
    Qiuyan Li, Xuye Jiang, Yujia Zhou, Yingying Gu, Yijie Ding, Jing Luo, Nengzhi Pang, Yan Sun, Lei Pei, Jie Pan et al. · 2023 · International Journal of Molecular Sciences
  7. Ginsenoside Rh4 prevents endothelial dysfunction as a novel AMPK activator
    Jiawei Zhang, Weiqiang Lv, Xuyun Liu, Zhenyu Sun, Mengqi Zeng, Jiahao Kang, Qi Zhang, Fuying Liu, Shaozhou Ma, Jiacan Su et al. · 2024 · British Journal of Pharmacology
  8. Pyrazolone derivative C29 protects against HFD-induced obesity in mice via activation of AMPK in adipose tissue
    Bohan Li, Mei Zhang, Yanan Duan, Lin Shuai, Haowen Jiang, Jia Li, Fajun Nan, Jingya Li · 2020 · Acta Pharmacologica Sinica
  9. The Pursuit of Enzyme Activation: A Snapshot of the Gold Rush
    Mingxing Teng, Damian W. Young, Zhi Tan · 2022 · Journal of Medicinal Chemistry
  10. P‐cresyl sulfate causes mitochondrial hyperfusion in H9C2 cardiomyoblasts
    Tien‐Hung Huang, Hon‐Kan Yip, Cheuk‐Kwan Sun, Yi‐Ling Chen, Chih‐Chao Yang, Fan‐Yen Lee · 2020 · Journal of Cellular and Molecular Medicine
  11. Metformin—mechanisms of its glycemia-reducing effect
    Jürgen Drewe, Marc Foretz, Stephan Krähenbühl · 2025 · Pharmacological Reviews
  12. Unveiling the Mechanism of Protective Effects of Tanshinone as a New Fighter Against Cardiovascular Diseases: A Systematic Review
    Mohammad Mahdi Dabbaghi, Hesan Soleimani Roudi, Rozhan Safaei, Vafa Baradaran Rahimi, Mohammad Reza Fadaei, Vahid Reza Askari · 2024 · Cardiovascular Toxicology
  13. Metabolic Regulation of Cardiovascular Aging
    Michael Gao, Toren Finkel · 2025 · Current Cardiology Reports
  14. The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury
    Marina Katerelos, Kurt Gleich, Geoff Harley, Kim Loh, Jonathan S. Oakhill, Bruce E. Kemp, David Peter De Souza, Vinod K. Narayana, Melinda T. Coughlan, Adrienne Laskowski et al. · 2024 · Biomedicine & Pharmacotherapy
  15. Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction‑associated fatty liver disease
    Guolin Miao, Wenxi Zhang, Yitong Xu, Yiran Liu, Pingping Lai, Jiabao Guo, Gong‑Lie Chen, J.-Z. Chen, Zihao Zhou, Yan‑Wei Li et al. · 2025 · Military Medical Research
  16. MK8722 alleviates osteoarthritis by activating Sesn2 and transcriptionally upregulating BNIP3 to promote mitophagy and inhibit chondrocyte ferroptosis
    Haochen Wang, Zhenqiang Zhao, Jianbang Su, Wenzheng Chen, Haoyan Shi, Tianqi Gao, Minghao Yu, Lunhao Bai, Peng Dong, Qian Zhang et al. · 2025 · Journal of Advanced Research
  17. ZG02 Improved Hepatic Glucose Metabolism and Insulin Sensitivity via Activation of AMPK/Sirt1 Signaling Pathways in a High-fat Diet/Streptozotocin-induced Type 2 Diabetes Model
    Yi Zhang, Bo Zhou, Min Wen, Mi Hu, Jin-Gang Peng, Ying Wang, Linlin Fan, Lei Tang · 2020 · Diabetes Metabolic Syndrome and Obesity
  18. Frequent loss-of-function mutations in the AMPK-α2 catalytic subunit suggest a tumour suppressor role in human skin cancers
    Fiona A. Ross, Simon A. Hawley, Fiona M. Russell, Nicola Goodman, David Grahame Hardie · 2023 · Biochemical Journal
  19. In silico screening of a novel scaffold for fructose-1,6-bisphosatase (FBPase) inhibitors
    Yunyuan Huang, Bo Chi, Yanhong Xu, Rongrong Song, Lin Wei, Li Rao, Lingling Feng, Yanliang Ren, Jian Wan · 2018 · Journal of Molecular Graphics and Modelling
  20. Myeloid AMPK signaling restricts fibrosis but is not required for metformin improvements during CDAHFD-induced NASH in mice
    Julia R.C. Nunes, Conor O’Dwyer, Peyman Ghorbani, Tyler K.T. Smith, Samarth Chauhan, Victoria N. Robert-Gostlin, Madison D. Girouard, Benoı̂t Viollet, Marc Foretz, Morgan D. Fullerton · 2024 · Journal of Lipid Research
  21. AMPK associates with and causes fragmentation of the Golgi by phosphorylating the guanine nucleotide exchange factor GBF1
    Jordana B. Freemantle, Mhairi C. Towler, Emma R. Hudson, Thomas Macartney, Monika Zwirek, David J.K. Liu, David A. Pan, Sreenivasan Ponnambalam, David Grahame Hardie · 2024 · Journal of Cell Science
  22. Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: Any place for drug repurposing?
    Elisa Avolio, Barbara Bassani, Marzia Campanile, Khaled Abdelsattar Kassem Mohammed, Paola C. Muti, Antonino Bruno, Gaia Spinetti, Paolo Roberto Madeddu · 2024 · Pharmacological Reviews
  23. AMPK phosphosite profiling by label-free mass spectrometry reveals a multitude of mTORC1-regulated substrates
    William J. Smiles, Ashley J. Ovens, Dingyi Yu, Naomi X.Y. Ling, Andrea C. Poblete Goycoolea, Kaitlin R. Morrison, Emmanuel O. Murphy, Astrid Glaser, Sophie F. Monks O’Byrne, Scott Taylor et al. · 2025 · npj Metabolic Health and Disease
  24. Research progress on the role of FGF21 in insulin resistance
    Haixin Zhang, Rongyu Zhu, Quanhao Sun, Likun Du · 2025 · Frontiers in Endocrinology
  25. Nanoparticle delivery of AMPK activator 991 prevents its toxicity and improves muscle homeostasis in Duchenne muscular dystrophy
    Ilaria Andreana, Ananga Ghosh, Mathieu Repellin, Anita E. M. Kneppers, Sabrina Ben Larbi, Federica Tifni, Aurélie Fessard, Marion J. Martin, Jacqueline Sidi‐Boumedine, David Kryza et al. · 2025 · Molecular Therapy — Methods & Clinical Development
  26. Therapeutic assessment of a novel mitochondrial complex I inhibitor in in vitro and in vivo models of Alzheimer's disease
    Sergey Trushin, Thi Kim Oanh Nguyen, Andrea Stojakovic, Mark Ostroot, J. Trey Deason, Su-Youne Chang, Liang Zhang, Slobodan I Macura, Toshihiko Nambara, Wenyan Lü et al. · 2025 · EBioMedicine
  27. Suppression of hepatosteatosis by isarubrolone C through AMPK-dependent regulation of lipophagy and lipid metabolism
    Bo Chen, Yuan-yuan Ma, Zhang Miao-qing, Rui Zhang, Shufen Li, Lin-zhuan Wu, Jingpu Zhang · 2025 · Metabolism
  28. Inhibition of basal and glucagon-induced hepatic glucose production by 991 and other pharmacological AMPK activators
    Manuel Johanns, Cyril Corbet, Roxane Jacobs, Melissa Drappier, Guido T. Bommer, Gaëtan Herinckx, Didier Vertommen, Nicolas Tajeddine, David Young, Joris Messens et al. · 2022 · Biochemical Journal
  29. Activation of AMP-activated protein kinase (AMPK) through inhibiting interaction with prohibitins
    Shuhei Kanagaki, Yusuke Tsutsui, Naoki Kobayashi, Takashi Komine, Minoru Ito, Yunike Akasaka, Michiaki Nagasawa, Tomohiro Ide, Naoki Omae, Kazuhisa Nakao et al. · 2023 · iScience
  30. Novel substituted pyrazolone derivatives as AMP-activated protein kinase activators to inhibit lipid synthesis and reduce lipid accumulation in ob/ob mice
    Mei Zhang, Zhifu Xie, Runtao Zhang, Da-Kai Chen, Min Gu, Shichao Cui, Yangming Zhang, Xinwen Zhang, Yanyan Yu, Jia Xuan Li et al. · 2018 · Acta Pharmacologica Sinica
  31. SIRT6 in Regulation of Mitochondrial Damage and Associated Cardiac Dysfunctions: A Possible Therapeutic Target for CVDs
    Divya K.P, Navjot Kanwar, P.V. Anuranjana, Gautam Kumar, Fathima Beegum, Krupa Thankam George, Nitesh Kumar, Krishnadas Nandakumar, Abhinav Kanwal · 2024 · Cardiovascular Toxicology
  32. Exploring the Anti-Diabetic Potential of Quercetagitrin through Dual Inhibition of PTPN6 and PTPN9
    Geetanjali B. Gone, Geon Go, Gibeom Nam, Woojoo Jeong, Hyemin Kim, Soah Lee, Sang J. Chung · 2024 · Nutrients
  33. AMPK-mediated regulation of endogenous cholesterol synthesis does not affect atherosclerosis in a murine Pcsk9-AAV model
    Tyler K.T. Smith, Peyman Ghorbani, Nicholas D. LeBlond, Julia R.C. Nunes, Conor O’Dwyer, Nia Ambursley, Claire Fong-McMaster, Lucía Minarrieta, Leah A. Burkovsky, Rama El-Hakim et al. · 2024 · Atherosclerosis
  34. H3 relaxin ameliorates mitochondrial quality control and apoptosis in cardiomyocytes of type 2 diabetic rats via activation of the AMPK pathway
    Jingzhi Wang, Kelaier Yang, Chunnan Liu, Fan Wang, Xinfang Liang, Jinfeng Wu, Siting Hong, Xinhua Yin, Xiaohui Zhang · 2024 · International Immunopharmacology
  35. The AMPK allosteric activator MK ‐8722 improves the histology and spliceopathy in myotonic dystrophy type 1 ( DM1 ) skeletal muscle
    Aymeric Ravel‐Chapuis, Chimène Fahmi, Jonathan Gobin, Bernard Jean Jasmin · 2024 · The FASEB Journal
  36. AMPK signaling in osteoarthritis: from mechanisms to targeted therapeutics
    Lin Chen, Xiuhua Hu, Xinyi Wu, Xin Zhang, Yuxin Han, Yi Liu, Guangyao Chen, Qingwen Tao · 2025 · Frontiers in Pharmacology
  37. O304 ameliorates hyperglycemia in mice by dually promoting muscle glucose effectiveness and preserving β-cell function
    Stefan Norlin, Jan Axelsson, Madelene Ericsson, Helena Edlund · 2023 · Communications Biology
  38. AMPK and O-GlcNAcylation: interplay in cardiac pathologies and heart failure
    Ettore Vanni, Christophe Beauloye, Sandrine Horman, Luc Bertrand · 2024 · Essays in Biochemistry
  39. AMPK promotes TFEB transcriptional activity through dephosphorylation at both MTORC1-dependent and -independent sites
    Florentina Negoita, Conchita Fraguas Bringas, Kristina Hellberg, Katarzyna Müller Luda, Hongling Liu, Zhiyuan Li, Joyceline Cuenco, Jin‐Feng Zhao, Gajanan J. Sathe, Ian G. Ganley et al. · 2026 · Autophagy
  40. Mitochondrial quality control in human ageing and longevity
    Anna Picca, Luigi Ferrucci · 2026 · Nature Metabolism
  41. The pro-drug C13 activates AMPK by two distinct mechanisms
    Jordana B. Freemantle, Dinesh Singh Shah, Dylan M. Lynch, Alessio Ciulli, Harinder S. Hundal, David Grahame Hardie · 2024 · Biochemical Journal
  42. Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway
    Xuxia Li, Peng Zhang, Yang Yang, Jing-jing Wang, Yanjun Zheng, Jiliang Tan, Shenyan Liu, Yong‐Ming Yan, Youyi Zhang, Yong‐Xian Cheng et al. · 2021 · Acta Pharmacologica Sinica
  43. Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis
    Sung-Jun Park, Faiyaz Ahmad, Robert J. Bahde, Andrew Philp, Jeonghan Kim, Tianjiao Huang, Myung K. Kim, William C. Trenkle, Jay H. Chung · 2021 · PLoS ONE
  44. AMPK activation by SC4 inhibits noradrenaline-induced lipolysis and insulin-stimulated lipogenesis in white adipose tissue
    Sheng-Ju Chuang, Manuel Johanns, Sébastien Pyr dit Ruys, Gregory R. Steinberg, Bruce E. Kemp, Benoı̂t Viollet, Mark H. Rider · 2021 · Biochemical Journal
  45. Combinatorial therapies for rescuing myotonic dystrophy type 1 skeletal muscle defects
    Aymeric Ravel‐Chapuis, Bernard Jean Jasmin · 2022 · Trends in Molecular Medicine
  46. Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response
    Andréa Cottignies-Calamarte, Flora Marteau, Feifan He, Sandrine Belouzard, Jean Dubuisson, Daniela Tudor, Benoı̂t Viollet, Morgane Bomsel · 2025 · Journal of Virology
  47. Activin receptor type IIA/IIB blockade increases muscle mass and strength, but compromises glycemic control in mice
    Michala Carlsson, Emma Frank, Joan Miquel Màrmol, Mona Sadek Ali, Steffen Henning Raun, Edmund Battey, Nicoline R. Andersen, Andrea Irazoki, Camilla Lund, Carlos Henríquez‐Olguín et al. · 2025 · Molecular Metabolism
  48. M1-linked ubiquitination by LUBAC regulates AMPK signalling and the response to energetic stress
    Camilla Reiter Elbæk, Sophie Gradinaru, Anna M. Dahlström, Alexander Frueh, Akhee Sabiha Jahan, Joyceline Cuenco, Anna L. Aalto, John Rizk, Simon A. Hawley, Sarah N. J. Franks et al. · 2026 · Cell Death and Differentiation
  49. Canonical and Alternative Pathways (Insulin and Exercise) of GLUT4 Synthesis, Signaling, Intracellular Clustering, and Recruitment to the Plasma Membrane
    Arnulfo Ramos‐Jiménez, Mariazel Rubio-Valles, Jaime Guereca Arvizuo, Marco Antonio Juárez-Oropeza, Javier A. Ramos-Hernández, Isaac Armando Chávez-Guevara, Everardo González-Rodríguez, Verónica Moreno-Brito, Rosa Patricia Hernández Torres · 2026 · International Journal of Molecular Sciences
  50. In Silico and In Vitro Approach to Assess Direct Allosteric AMPK Activators from Nature
    Benjamin Kirchweger, Andreas Wasilewicz, Katrin Fischhuber, Ammar Tahir, Ya Chen, Elke H. Heiß, Thierry Langer, Johannes Kirchmair, Judith Maria Rollinger · 2022 · Planta Medica
  51. Extrarenal Benefits of SGLT2 Inhibitors in the Treatment of Cardiomyopathies
    Veera Ganesh Yerra, Kim Alexander Connelly · 2024 · Physiology
  52. AMPK
    Daniel Garcia, Maria M. Mihaylova, Reuben J. Shaw · 2020
  53. GENI as an AMPK Activator Binds α and γ Subunits and Improves the Memory Dysfunction of Alzheimer’s Disease Mouse Models via Autophagy and Neuroprotection
    Ying Wang, Lanjie Li, Danni Chen, Jiaheng Shan, Meijuan Yi, Hiroyuki Osada, Minoru Yoshida, Lan Xiang, Jianhua Qi · 2025 · Antioxidants
  54. Trigonelline Improves Metabolism and Cardiac Function of HFpEF Mice Via Gut Microbiome Alterations‐Mediated AMPK Activation
    Zhe Cheng, Xiaowen Wang, Yu Jiang, Xiaorong Li, Qing Tang, Can Qu, Ding Yang, Yuanjing Li, Yong Xia, Yongzheng Guo · 2025 · Advanced Science
  55. AMPK: an enzyme that may be effective in cancer and metabolic diseases
    Sümeyye Güney-Kalkan, Meltem Ceylan‐Ünlüsoy · 2025 · Discover Oncology
  56. Common and distinct roles of AMPKγ isoforms in small-molecule activator-stimulated glucose uptake in mouse skeletal muscle
    Dipsikha Biswas, Ever Espino-González, Danial Ahwazi, Jordana B. Freemantle, Amy M. Ehrlich, Charline Jomard, Jonas Brorson, Agnete N Schou, Jean Farup, Julien Gondin et al. · 2025 · Molecular Metabolism
  57. Characteristics of Myocardial Structure and Central Carbon Metabolism during the Early and Compensatory Stages of Cardiac Hypertrophy
    Yuan Chen, Yu-Mei Luo, Dong Li, Haiqiong Liu, Xiaoqin Luo, Xinlei Zhang, Yuanna Ling, Wei Ouyang · 2024 · Journal of Proteome Research
  58. Allosteric activation of AMPK ADaM’s site by structural analogs of Epigallocatechin and Galegine: computational molecular modeling investigation
    Mohnad Abdalla, Abdeen Tunde Ogunlana, Modinat Wuraola Akinboade, Ridwan Olajire Muraina, Oyindamola Anthonia Adeosun, Onyekachi Juliet Okpasuo, Olamide Tosin Olaoba, Abdulaziz Alouffi, Aqel Albutti, Zeyad Kurdee et al. · 2025 · In Silico Pharmacology
  59. Ebastine-mediated destabilization of E3 ligase MKRN1 protects against metabolic dysfunction-associated steatohepatitis
    Seungyeon Kim, Hyun-Ji Han, Hyunjin K. Rho, Subin Kang, Sulagna Mukherjee, Jiwoo Kim, Doyoun Kim, Hyuk Wan Ko, Sang Min Lim, Seung‐Soon Im et al. · 2025 · Cellular and Molecular Life Sciences
  60. Modulation of Glucagon Signaling
    Alessandro Pocai · 2019 · JACC Basic to Translational Science
  61. AMPK as a central regulator of metabolic memory: mechanisms and therapeutic opportunities
    Wajid Aslam Khan, Sourbh Suren Garg, Kaneeka Banyal, Jeena Gupta · 2026 · Journal of Diabetes & Metabolic Disorders
  62. [Metformin mitigates doxorubicin-induced cardiotoxicity via the AMPK pathway].
    Jin Wei, Quanxin Yang, Lin Lin, Chuandong Zhu, Jin Wei · 2023 · PubMed Central
  63. Direct β1/ β2 AMPK activation reduces liver steatosis but not fibrosis in a mouse model of non-alcoholic steatohepatitis
    KARLY M. MATHER, Michelle L. Boland, Emma Rivers, Abhishek Srivastava, Marianne Schimpl, PAUL E. HEMSLEY, James D. Robinson, Paul Wan, JOSEFINE L. HANSEN, Jon A. Read et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Novel AMP-activated protein kinase activators and their potential for mitigating renal injury and fibrosis
    Geoff Harley, Peter F. Mount · 2025 · Journal of Pharmacology and Experimental Therapeutics
  65. Neg-entropy is the true drug target for chronic diseases
    Rui P. Li, Tian-Le Gao, Gang Ren, Lulu Wang, Jian‐Dong Jiang · 2025 · Acta Pharmaceutica Sinica B
  66. Direct AMPK Activation Confers Mutation‐Independent Therapeutic Benefit in Duchenne Muscular Dystrophy
    Sean Y. Ng, Andrew I. Mikhail, Stephanie R. Mattina, Magda A. Lesinski, Irena A. Rebalka, Sophie I. Hamstra, Donald Xhuti, Val Andrew Fajardo, Mark Andrew Tarnopolsky, Joshua P. Nederveen et al. · 2026 · Journal of Cachexia Sarcopenia and Muscle
  67. Catalytic strategies for post-translational modifications regulating protein higher-order structure and properties
    Yuki Yamanashi, Motomu Kanai · 2026 · Chemical Society Reviews
  68. AMPK Signalling in Heart Failure: From Metabolic Sensor to Context-Dependent Therapeutic Target
    Rayan Arzouni, Reem F. M. Aazar, Seif Asakrieh, Seif Cattan, Aleksandar Jovanović · 2026 · Biomedicines
  69. Identification of AdipoRon analogues as novel activators of AMPK for the treatment of type 2 diabetes
    Chao Lin, Geng Sun, Yi Li · 2024 · RSC Medicinal Chemistry
  70. A New Understanding of Metformin
    David Grahame Hardie · 2021 · Elsevier eBooks
  71. Role of AMP-activated protein kinase and sirtuins as antiaging proteins
    Manjula Ramu, Sonali S. Vishal, Neha Gogia · 2022 · Elsevier eBooks
  72. The Metabolic Sensor Adenosine Monophosphate–Activated Protein Kinase Regulates Apoptosis in Nonalcoholic Steatohepatitis
    Maria Eugenia Guicciardi, Yasuhiko Nakao, Gregory James Gores, , · 2020 · Hepatology
  73. Sialin2 Functions as a Mammalian Nitrate Sensor to Sustain Mitochondrial Homeostasis
    Xiaoyu Li, Songyue Wu, Zichen Cao, Ou Jiang, Shaorong Li, Xinyue Chen, Yao Feng, Bo Zhou, Chen Zhang, Guozhi Xiao et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Role of AMPK/ULK1 signaling in mitophagy
    Roberto Iorio, Sabrina Petricca · 2024 · Elsevier eBooks
  75. Isoguanosine-Induced ER Stress via AMPK Enhances Chemosensitivity in OSCC
    Jie J. Yao, Siyu Song, Tianrui Liu, J. Wang, C. Li, Jiang Liu, Yao Zong YUAN, H. Zhao · 2025 · Journal of Dental Research
  76. AMPK : Accumulating Evidence in Support of its role in Dual Regulation of Vascular Function and Metabolism During Human Pregnancy
    LORNA GRINDLAY MOORE, Stephanie R. Wesolowski, Ramón A. Lorca, Colleen Glyde Julian · 2025 · Acta Physiologica
  77. PRKAA2 mediates the pathogenesis of metabolic dysfunction-associated steatotic liver disease via PI3K/AKT signaling pathway
    Jiayi Li, Guiling Wu, Zihao Li, Xinghuan Liang, Yiyu Chen, Bing Qing Yang, Jing Xian, Tingting Deng, Cuihong Chen, Li Li et al. · 2025 · Human Genomics
  78. Photonic Crystal-Enhanced Fluorescence Response of MOFs for the Detection of Metabolism-Related Molecules
    Qi Fang Zhu, Yonghuan Chen, Zhihong Lin, Jianlin Lin, Ziheng Zhang, Shuhuai Pang, Jianghai Zhu, Dan Li, Guo‐Hong Ning, Fengyu Li · 2025 · ACS Applied Materials & Interfaces
  79. AMPK: a master regulator of mitochondrial quality and quantity
    Reuben J. Shaw, Ian G. Ganley, Julien Prudent, David Grahame Hardie · 2026 · Trends in Cell Biology
  80. ATIC as a link between antirheumatic drugs and regulation of energy metabolism in skeletal muscle
    Klemen Dolinar · 2020 · Periodicum Biologorum
  81. Sapogeninas de Chenopodium quinoa Willd como activadores potenciales de AMPKβ2 para la homeostasis independiente de insulina
    Ricardo Enrique Grados Torrez, Dayana Pamela Bello- Kopa, Ricardo Enrique Grados-Torrez · 2023 · Gaceta Médica Boliviana
  82. Pan AMPK activation protects tubules in rat ischemic acute kidney injury
    Henriette Frikke‐Schmidt, Kamal A. Albarazanji, Jenson Qi, David Frederick, Janos Steffen, Shanker Kalyana Sundaram, Rong Meng, Zheng Huang Devine, Tao Chen, Qiu Li et al. · 2024 · Journal of Pharmacology and Experimental Therapeutics
  83. The thienopyridine A-769662 and benzimidazole 991 inhibit human TASK-3 potassium channels in an AMPK-independent manner
    Esraa A. Said, Ryan W. Lewis, Mark L. Dallas, Chris Peers, Fiona A. Ross, Asier Unciti‐Broceta, David Grahame Hardie, A. Mark Evans · 2024 · Biochemical Pharmacology
  84. Elucidation of Mechanism of Action in Drug Invention: Using Stable Isotope Tracers to Unravel Biochemical Kinetics
    Rebecca A. Kohnz, Dan Zhou, Bin Lou, Huifang Yao, David McKenney, Dhiraj Dokwal, Ruth Villanueva, Heidi E. Kocalis, Jeanine E. Ballard, Jennifer Piesvaux et al. · 2025 · Pharmacology Research & Perspectives
  85. Evaluation of AMPK activity in mice by measuring activator-induced glucose uptake
    Peng Jiang, Li Zhi, Lejiao Ren, Xinli Hu, Rui‐Ping Xiao · 2021 · STAR Protocols
  86. Analgesic Effectiveness and Dorsal Root Ganglia Protein Modulation of a Peripheral Adenosine Monophosphate Kinase Alpha Activator (O304) Following Lumbar Disk Puncture in the Mouse
    Vaskar Das, Michael B. Basovich, Jeffrey S. Kroin, Asokumar Buvanendran, Robert J. McCarthy · 2022 · Anesthesia & Analgesia
  87. AMP-Activated Protein Kinase γ2 to the Rescue in Ischemic Heart
    Ye Ding, Ming‐Hui Zou · 2017 · Circulation Research
  88. Novel torin1-sensitive phosphorylation sites on the metabolic regulator AMPK revealed by label-free mass spectrometry
    William J. Smiles, Ashley J. Ovens, Dingyi Yu, Naomi X.Y. Ling, Kaitlin R. Morrison, Ashfaqul Hoque, John W. Scott, Sandra Galić, Christopher G. Langendorf, Bruce E. Kemp et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  89. AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity
    Zhen Sun, Bernard Linares, Cassidy Urdiales, Fiyad Al-sarmi, Nagireddy Putluri, Jeanine L. Van Nostrand · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Inhibiting lysosomal aldolase: a magic bullet for AMPK activation in treating metabolic disease?
    David Carling · 2022 · Life Metabolism
  91. AMPK Signaling Regulates Epithelioid Hemangioendothelioma Cell Growth
    Ryan Kanai, Sarah McMullan, Pukar Baniya, Roselyn S. Dai, Emily Norton, Kaila Lasher, Chloe T Purello, Caleb Nathaniel Seavey, Brian P. Rubin, John M. Lamar · 2025 · Cancers
  92. Exploring natural AMPK activators from bioactive compounds in fenugreek and oyster mushroom for management of type 2 diabetes
    Sanaullah Mazumdar, Md. Omar Faruque, Tuhibbul Islam, Md. Ruhul Amin, Md. Abdur Rakib, Md. Alauddin · 2025 · Scientific Reports
  93. Global loss of metabolic responsiveness and elevated enzyme in leptin deficient obese mice during starvation
    D.F. Li, Keigo Morita, Toshiya Kokaji, Atsushi Hatano, Akiyoshi Hirayama, Tomoyoshi Soga, Yutaka Suzuki, Masaki Matsumoto, Takaho Tsuchiya, Haruka Ozaki et al. · 2026 · npj Systems Biology and Applications
  94. Redox‐Guided Metabolic Control in Cancer: Integration of the Reactive Oxygen Species–AMP‐Activated Protein Kinase–Sirtuin Axis in Tumour Adaptation and Therapy
    Fathe Singh · 2026 · Journal of Biochemical and Molecular Toxicology
  95. KCMF1 promotes MASLD progression via K48-linked ubiquitination and degradation of AMPKα
    Min Tang, Yunqin Ma, Jiaqi Wang, Han Cao, Shuangshuang Yao, Xiaohui Wei, Yijiong Tan, Hua Yang, Yilin, Bin Hu et al. · 2026 · Metabolism
  96. Activation of AMPK as a therapeutic strategy for FBXL4-related mitochondrial DNA depletion syndrome
    Aniketh Bishnu, Juan Zapata‐Muñoz, Robert William Taylor, Kei Sakamoto, Ian G. Ganley · 2026 · EMBO Molecular Medicine
  97. AMPK phosphorylation proceeds through hierarchical proteoform cascades revealed by integrated mass spectrometry
    Boris Krichel, Hsin‐Ju Chan, Liam J. Bandura, Zhan Gao, Man‐Di Wang, Holden T. Rogers, Sean J. McIlwain, Charlotte Uetrecht, Ying Ge · 2026 · Science Advances
  98. Candidate molecular targets uncovered in mouse lifespan extension studies
    Maria V. Vedunova, Olga Borysova, G. Kozlov, Anna-Maria D. Zharova, Ivan Morgunov, Alexey Moskalev · 2024 · Expert Opinion on Therapeutic Targets
  99. State of Knowledge and Recent Advances in Prevention and Treatment of Mitochondrial Dysfunction in Obesity and Type 2 Diabetes
    Carles Cantó · 2019 · Elsevier eBooks
  100. Probing Hepatic Glucose Metabolism via 13C NMR Spectroscopy in Perfused Livers—Applications to Drug Development
    Corin O. Miller, Jin Cao · 2021 · Metabolites